Benzinga | Aug 5, 2021 04:13PM EDT

Anika Therapeutics Q2 EPS $0.09 Beats $(0.06) Estimate, Sales $38.10M Beat $34.76M Estimate

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.06) by 250 percent. This is unchanged from the same period last year. The company reported quarterly sales of $38.10 million which beat the analyst consensus estimate of $34.76 million by 9.61 percent. This is a 24.19 percent increase over sales of $30.68 million the same period last year.